To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Nastech CEO Presents RNA Interference Pandemic Influenza Program at Beyond Genome Conference
Steven C. Quay, M.D., Ph.D., Chairman, President and CEO of Nastech Pharmaceutical Company Inc. has presented the company’s RNAi pandemic influenza program at Cambridge Healthtech Institute’s 5th annual RNA Interference conference.
Dr. Quay’s presentation summarized the results and status of Nastech’s siRNA pandemic influenza program and the company’s RNAi platform technology, delivery technology, and pre-clinical success with continued progression toward human clinical trials.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
